The contribution of Gianni Bonadonna to the history of chemotherapy

Cancer Chemotherapy and Pharmacology

Volumn 60, Issue 3, 2007, Pages 309-312

  Ribatti, Domenico ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Breast cancer; Chemotherapy; History of medicine; Hodgkin's disease; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVANCED CANCER; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HODGKIN DISEASE; HUMAN; LYMPHOMA; MASTECTOMY; MORBIDITY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SCIENTIST; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BREAST NEOPLASMS; CISPLATIN; DACARBAZINE; DOXORUBICIN; FEMALE; FLUOROURACIL; HISTORY, 20TH CENTURY; HODGKIN DISEASE; HUMANS; ITALY; METHOTREXATE; NEOPLASMS; VINBLASTINE;

EID: 34250622896     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-006-0410-7     Document Type: Review

References (31)

1. Marchall EK Jr (1964) Historical perspectives in chemotherapy. Adv Chemother 1:1
2. Fisher B, Gebhardt MC (1978) The evolution of breast cancer surgery: past, present and future. Semin Oncol 5:385-394
3. Canellos GP, Devita VT, Gold GL, Chabner BA, Schein PS, Young RC (1974) Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J 1:218-220
4. Canellos GP, Devita VT, Gold GL, Chabner BA, Schein PS, Young RC (1976) Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med 84:389-392
5. De Lena M, Brambilla C, Morabito A, Bonadonna G (1975) Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. Cancer 35:1108-1115
6. Brambilla C, De Lena M, Rossi A, Valgussa P, Bonadonna G (1976) Response and survival in advanced breast cancer after two non-cross-resistant combinations. Br Med J 1:801-804
7. Canellos GP, Pocock SJ, Taylor SG III, Sears ME, Klaasen DJ, Band PR (1976) Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with l-phenylalanine mustard. Cancer 38:1882-1886
8. Bonadonna G, Brusamolino E, Valagussa P et al (1976) Combined chemotherapy as adjuvant treatment in operable breast cancer. New Engl J Med 294:405-410
9. Fisher B, Carbone P, Economou SG et al (1975) l-Phenylalanine mustard (l-PAM) in the management of primary breast cancer: a report of early findings. N Engl J Med 292:117-122
10. Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C (1995) Adjuvant cyclophosphamide, metotrexate, and fluorouracil in node-positive breast cancer. The results of 20 years of follow-up. New Engl J Med 332:901-906
11. Bonadonna G, Moliterni A, Zambetti M et al (2005) 30 Years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ 330:217
12. Hersh SM (1968) Chemical and biological warfare: America's hidden arsenal. Bobbs Merrill, New York
13. Infield GB (1971) Disaster at Bari. MacMillan, New York
14. Gilman A, Philips FS (1946) The biological actions and therapeutic applications of b-chloroethyl amines and sulfides. Science 103:409-415
15. Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman AZ, McLennan MJ (1946) Nitrogen mustard therapy. Use of methyl-bis (beta-chloroethyl) amino hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. J Am Med Assoc 132:126-132
16. Scott IL (1963) The effect of nitrogen mustard and maintenance chlorambucil in the treatment of advanced Hodgkin's disease. Cancer Chemother Rep 27:27-32
17. Skipper H, Schabel F, Wilcox W (1964) Experimental evaluation of potential anticancer agents. Cancer Chemother Rep 35:1-111
18. Moxley J, De Vita VJ, Brace K, Frei E (1976) Intensive chemotherapy and X-irradiation in Hodgkin's disease. Cancer 27:1258-1263
19. Lacher MJ, Durant J (1965) Combined vinblastine and chlorambucil therapy of Hodgkin's disease. Ann Intern Med 62:468-476
20. De Vita VT, Serpick A, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881-895
21. De Vita VT, Canellos GP, Chabner B, Schein P, Hubbard SP, Young RC (1975) Combination chemotherapy in the treatment of Hodgkin's disease. Ann Intern Med 73:881-895
22. Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C (1975) Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36:252-259
23. Bonadonna G, Beretta G, Tancini G et al (1975) Adriamycin (NSC-123127) studies at the Istituto Nazionale Tumori, Milan. Cancer Chemother Rep 6:231-245
24. Bonadonna G (1982) Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 42:4309-4320
25. Bonadonna G, Santoro A (1982) ABVD chemotherapy in the treatment of Hodgkin's disease. Cancer Treat Rev 9:21-35
26. Bonadonna G, Santoro A (1982) Evolution in the treatment strategy of Hodgkin's disease. Adv Cancer Res 36:257-293
27. Santoro A, Bonadonna G, Valagussa P et al (1987) Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease. Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5:27-38
28. Bonadonna G, Valagussa P, Santoro A (1986) Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. Ann Intern Med 104:739-746
29. Viviani S, Bonadonna G, Santoro A et al (1996) Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease, ten years results. J Clin Oncol 14:1421-1430
30. Canellos GP, Anderson JR, Propert KJ et al (1992) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, ABVD or MOPP alternating with ABVD. New Engl J Med 327:1478-1484
31. Duggan DB, Petroni GR, Johnson L et al (2003) Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease, report of an intergroup trial. J Clin Oncol 21:607-614